Tyra Biosciences, Inc. TYRA
21.53 USD +0.15 (+0.73%)
At closeNov 4, 2026, 4:00 PM EST
21.53 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
20.78 Day range 21.91
13.35 52-week range 40.65
- YTD
- -18.12%
- 1 year
- +43.50%
Financial health
Altman Z-Score
24.07 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -13.1×
FY 2019 5y median -9.2× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 6.0×
FY 2019 5y median 2.3× FY 2025
P/FCF -16.4×
FY 2019 5y median -11.6× FY 2025
EV/EBITDA -12.5×
FY 2019 5y median -8.3× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -6.1%
FY 2019 5y median -8.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -46.3%
FY 2019 5y median -25.2% FY 2025
ROIC -50.1%
FY 2019 5y median -29.8% FY 2025
ROA -42.4%
FY 2019 5y median -23.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -27.4%
FY 2019 FY 2025
EPS (diluted) -33.1%
FY 2019 FY 2025
Free Cash Flow -35.3%
FY 2019 FY 2025
Financial Health
Current Ratio 14.7×
FY 2019 5y median 23.8× FY 2025
Quick Ratio 14.7×
FY 2019 5y median 23.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2019 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31